203 related articles for article (PubMed ID: 35273560)
1. Atrial Cardiopathy and Cryptogenic Stroke.
Kato Y; Takahashi S
Front Neurol; 2022; 13():839398. PubMed ID: 35273560
[TBL] [Abstract][Full Text] [Related]
2. Atrial Cardiopathy and Cryptogenic Stroke: A Cross-sectional Pilot Study.
Yaghi S; Boehme AK; Hazan R; Hod EA; Canaan A; Andrews HF; Kamel H; Marshall RS; Elkind MS
J Stroke Cerebrovasc Dis; 2016 Jan; 25(1):110-4. PubMed ID: 26476588
[TBL] [Abstract][Full Text] [Related]
3. The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: Rationale and methods.
Kamel H; Longstreth WT; Tirschwell DL; Kronmal RA; Broderick JP; Palesch YY; Meinzer C; Dillon C; Ewing I; Spilker JA; Di Tullio MR; Hod EA; Soliman EZ; Chaturvedi S; Moy CS; Janis S; Elkind MS
Int J Stroke; 2019 Feb; 14(2):207-214. PubMed ID: 30196789
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers of Atrial Cardiopathy and Atrial Fibrillation Detection on Mobile Outpatient Continuous Telemetry After Embolic Stroke of Undetermined Source.
Sebasigari D; Merkler A; Guo Y; Gialdini G; Kummer B; Hemendinger M; Song C; Chu A; Cutting S; Silver B; Elkind MSV; Kamel H; Furie KL; Yaghi S
J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1249-1253. PubMed ID: 28237125
[TBL] [Abstract][Full Text] [Related]
5. Distribution of atrial cardiomyopathy markers and association with atrial fibrillation detected after ischaemic stroke in the SAFAS study.
Didier R; Garnier L; Duloquin G; Meloux A; Sagnard A; Graber M; Dogon G; Benali K; Pommier T; Laurent G; Vergely C; Bejot Y; Guenancia C
Stroke Vasc Neurol; 2024 Apr; 9(2):165-173. PubMed ID: 37429637
[TBL] [Abstract][Full Text] [Related]
6. Secondary Stroke Prevention Following Embolic Stroke of Unknown Source in the Absence of Documented Atrial Fibrillation: A Clinical Review.
Kotadia ID; Sim I; Mukherjee R; O'Hare D; Chiribiri A; Birns J; Bhalla A; O'Neill M; Williams SE
J Am Heart Assoc; 2021 Jul; 10(13):e021045. PubMed ID: 34212774
[TBL] [Abstract][Full Text] [Related]
7. Cardioembolic Stroke: Past Advancements, Current Challenges, and Future Directions.
Kato Y; Tsutsui K; Nakano S; Hayashi T; Suda S
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891965
[TBL] [Abstract][Full Text] [Related]
8. Cryptogenic Stroke: Diagnostic Workup and Management.
Mac Grory B; Flood SP; Apostolidou E; Yaghi S
Curr Treat Options Cardiovasc Med; 2019 Dec; 21(11):77. PubMed ID: 31792625
[TBL] [Abstract][Full Text] [Related]
9. Atrial cardiopathy in embolic stroke of undetermined source.
Chen J; Gao F; Liu W
Brain Behav; 2021 Jun; 11(6):e02160. PubMed ID: 33942558
[TBL] [Abstract][Full Text] [Related]
10. Atrial Cardiopathy and Stroke Prevention.
Elkind MSV
Curr Cardiol Rep; 2018 Sep; 20(11):103. PubMed ID: 30209635
[TBL] [Abstract][Full Text] [Related]
11. Atrial cardiopathy: a mechanism of cryptogenic stroke.
Yaghi S; Kamel H; Elkind MSV
Expert Rev Cardiovasc Ther; 2017 Aug; 15(8):591-599. PubMed ID: 28718666
[TBL] [Abstract][Full Text] [Related]
12. Risk of Dementia Associated With Atrial Cardiopathy: The ARIC Study.
Johansen MC; Wang W; Zhang M; Knopman DS; Ndumele C; Mosley TH; Selvin E; Shah AM; Solomon SD; Gottesman RF; Chen LY
J Am Heart Assoc; 2022 Aug; 11(16):e025646. PubMed ID: 35946474
[TBL] [Abstract][Full Text] [Related]
13. Atrial Cardiopathy and Nonstenosing Large Artery Plaque in Patients With Embolic Stroke of Undetermined Source.
Kamel H; Pearce LA; Ntaios G; Gladstone DJ; Perera K; Roine RO; Meseguer E; Shoamanesh A; Berkowitz SD; Mundl H; Sharma M; Connolly SJ; Hart RG; Healey JS
Stroke; 2020 Mar; 51(3):938-943. PubMed ID: 31893985
[TBL] [Abstract][Full Text] [Related]
14. Atrial Cardiopathy Biomarkers and MRI-Based Infarct Patterns in Patients with Embolic Strokes of Undetermined Source.
Lee YK; Gwak BC; Yoon BA; Kim DH; Cha JK
J Stroke Cerebrovasc Dis; 2021 Aug; 30(8):105933. PubMed ID: 34157668
[TBL] [Abstract][Full Text] [Related]
15. Atrial cardiopathy: a broadened concept of left atrial thromboembolism beyond atrial fibrillation.
Kamel H; Okin PM; Longstreth WT; Elkind MS; Soliman EZ
Future Cardiol; 2015 May; 11(3):323-31. PubMed ID: 26021638
[TBL] [Abstract][Full Text] [Related]
16. The Relationship Between Atrial Cardiopathy Biomarkers and Prognosis of Patients With Embolic Stroke of Undetermined Source.
Ning Y; Wei M; Song W; Luo G
Front Cardiovasc Med; 2022; 9():829361. PubMed ID: 35360027
[TBL] [Abstract][Full Text] [Related]
17. P Wave Dispersion and Silent Atrial Fibrillation in Cryptogenic Stroke: The Pathogenic Role of Inflammation.
Acampa M; Lazzerini PE; Guideri F; Tassi R; Cartocci A; Martini G
Cardiovasc Hematol Disord Drug Targets; 2019; 19(3):249-252. PubMed ID: 30968778
[TBL] [Abstract][Full Text] [Related]
18. Anxiety is associated with increased risk for atrial cardiopathy.
Wang Z; Qin H; Chen G; Dai Y; Cai Y; Cheng X; Qian Y; Chu M; Lu X
Acta Neurol Belg; 2020 Dec; 120(6):1383-1388. PubMed ID: 32193730
[TBL] [Abstract][Full Text] [Related]
19. Atrial Cardiopathy and Sympatho-Vagal Imbalance in Cryptogenic Stroke: Pathogenic Mechanisms and Effects on Electrocardiographic Markers.
Acampa M; Lazzerini PE; Martini G
Front Neurol; 2018; 9():469. PubMed ID: 29971041
[TBL] [Abstract][Full Text] [Related]
20. N-terminal pro-brain natriuretic peptide shows diagnostic accuracy for detecting atrial fibrillation in cryptogenic stroke patients.
Fonseca AC; Brito D; Pinho e Melo T; Geraldes R; Canhão P; Caplan LR; Ferro JM
Int J Stroke; 2014 Jun; 9(4):419-25. PubMed ID: 23981586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
